Takahara K, Naiki T, Ito T, Nakane K, et al. Useful predictors of progression-free survival for Japanese patients with LATITUDE-high-risk metastatic castration-sensitive prostate cancer who received upfront abiraterone acetate. Int J Urol 2021 Dec 4. doi: 10.1111/iju.14754.
PMID: 34863085